Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Sep. 30, 2022
Current Assets:
Cash and cash equivalents	$ 26,430	$ 18,998
Accounts receivable, net of allowances of $140 and $81 as of December 31, 2022 and September 30, 2022, respectively	10,068	10,452
Contract assets — royalties and license fees	7,047	7,116
Inventories, net	12,724	11,819
Income tax receivable	121	2,438
Prepaids and other	8,072	6,764
Total Current Assets	64,462	57,587
Property and equipment, net	27,717	27,148
Intangible assets, net	29,262	28,145
Goodwill	43,308	40,710
Other assets	5,006	4,769
Total Assets	169,755	158,359
Current Liabilities:
Accounts payable	2,035	3,136
Accrued liabilities:
Compensation	4,410	8,929
Accrued other	7,048	5,854
Short-term borrowings		10,000
Deferred revenue	3,771	4,160
Total Current Liabilities	17,264	32,079
Long-term debt, net	29,495
Deferred revenue, less current portion	4,115	5,088
Deferred income taxes	2,102	2,027
Other long-term liabilities	9,518	10,773
Total Liabilities	62,494	49,967
Commitments and Contingencies (Note 11)
Stockholders’ Equity:
Series A Preferred stock — $.05 par value, 450 shares authorized; no shares issued and outstanding
Common stock - $.05 par value, 45,000 shares authorized;14126 and 14029 shares issued and outstanding as of December 31, 2022 and September 30, 2022, respectively	706	701
Additional paid-in capital	30,224	28,774
Accumulated other comprehensive loss	(4,617)	(9,874)
Retained earnings	80,948	88,791
Total Stockholders’ Equity	107,261	108,392
Total Liabilities and Stockholders’ Equity	$ 169,755	$ 158,359